Top Markets
#1 Pleasing Gold Pleasing Gold +812.04%
#2 Islamic Coin Islamic Coin +154.23%
#3 PulseChain PulseChain +56.32%
#4 BOOK OF MEME BOOK OF MEME +40.37%
#5 DogBull DogBull +36.05%
#6 Collect on Fanable Collect on Fanable +25.59%
#7 Nockchain Nockchain +19.04%
#8 Ontology Gas Ontology Gas +18.86%
#9 Neiro Neiro +18.78%
#10 rsERG rsERG +16.70%
Coin of the day
Pleasing Gold Pleasing Gold
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Theralase Technologies Inc. Theralase Technologies Inc.

Theralase Technologies Inc.

TLT
Classifica tra le azioni #26766
Theralase Technologies Inc., a clinical stage pharmaceutical company, engages... Theralase Technologies Inc., a clinical stage pharmaceutical company, engages in the research, development, and commercialization of light activated photo dynamic compounds and their associated drug formulations to treat cancers, bacteria, and viruses in Canada, the United States, and internationally. The company operates through Drug Division and Device Division segments. It designs, develops, manufactures, and markets super-pulsed laser technology for the healing of chronic knee pain, as well as for off-label use to heal various nerve, muscle, and joint conditions. In addition, the company develops TLD-1433, which is in Phase II clinical trial for the treatment of Bacillus Calmette Guérin-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma In-Situ. Further, it researches, develops, manufactures, and distributes controller-less cool laser therapy systems comprising TLC-900, TLC-300, and TLC-100 to healthcare practitioners primarily for the healing of pain. The company has a collaboration with the National Microbiology Laboratory, a Public Health Agency of Canada for the research and development of a Canadian-based SARS-CoV-2 vaccine. Theralase Technologies Inc. is based in Toronto, Canada.
Prezzo delle azioni
$0.12843896
Ultima sincronizzazione: 2026-08-19
Capitalizzazione di mercato
$37.98M
Variazione (1 giorno)
-2.78%
Variazione (1 anno)
-19.01%
Paese
CA
Scambia Theralase Technologies Inc. (TLT)

Categoria

Healthcare
Utile per Theralase Technologies Inc. (TLT)
Utile nel 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Theralase Technologies Inc., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, uguale a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Storico degli utili di Theralase Technologies Inc. dal 2026 al 2026
Utile alla fine di ogni anno
Anno Utile Cambia
Non abbastanza dati per le date fornite.
Utile per aziende simili o concorrenti
Azienda Utile Differenza negli utili Il paese
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
$7.51B -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
$5.15B -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
$5.56B -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
$3.86B -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
$1.42B -
US